# Diltiazem

## Diltelan 120mg

| 藥物代碼 | ODIL2 |
| :--- | :--- |
| 適應症 | Hypertension, chronic stable angina, vasospastic angina |
| 副作用 | &gt;10%: Cardiovascular: Peripheral edema \(5% to 15%\)1% to 10%:Cardiovascular: Lower extremity edema \(5% to 8%\), bradycardia \(3% to 4%\), first-degree atrioventricular block \(3% to 4%\), hypotension \(3% to 4%\), edema \(2% to 3%\), vasodilation \(2% to 3%\), extrasystoles \(2%\), palpitations \(1% to 2%\), angina pectoris \(&lt;2%\), bundle branch block \(&lt;2%\), cardiac failure \(&lt;2%\), complete atrioventricular block \(&lt;2%\), ECG abnormality \(&lt;2%\), second degree atrioventricular block \(&lt;2%\), syncope \(&lt;2%\), tachycardia \(&lt;2%\), ventricular premature contractions \(&lt;2%\), cardiac arrhythmia \(1%\)Central nervous system: Dizziness \(2% to 10%\), headache \(2% to 8%\), pain \(6%\), fatigue \(5%\), nervousness \(2%\), abnormal dreams \(&lt;2%\), abnormal gait \(&lt;2%\), amnesia \(&lt;2%\), depression \(&lt;2%\), drowsiness \(&lt;2%\), hallucination \(&lt;2%\), insomnia \(&lt;2%\), paresthesia \(&lt;2%\), personality changes \(&lt;2%\)Dermatologic: Skin rash \(1% to 2%\), pruritus \(&lt;2%\), skin photosensitivity \(&lt;2%\)Endocrine & metabolic: Gout \(1% to 2%\), albuminuria \(&lt;2%\), gynecomastia \(&lt;2%\), hyperglycemia \(&lt;2%\), hyperuricemia \(&lt;2%\), increased lactate dehydrogenase \(&lt;2%\), increased thirst \(&lt;2%\), weight gain \(&lt;2%\)Gastrointestinal: Dyspepsia \(1% to 6%\), abdominal enlargement \(2%\), nausea \(2%\), diarrhea \(1% to 2%\), anorexia \(&lt;2%\), constipation \(&lt;2%\), dysgeusia \(&lt;2%\), vomiting \(&lt;2%\), xerostomia \(&lt;2%\)Genitourinary: Impotence \(2%\), crystalluria \(&lt;2%\), nocturia \(&lt;2%\), sexual difficulty \(&lt;2%\)Hematologic & oncologic: Petechia \(&lt;2%\)Hepatic: Increased serum alanine aminotransferase \(&lt;2%\), increased serum alkaline phosphatase \(&lt;2%\), increased serum aspartate transaminase \(&lt;2%\)Hypersensitivity: Hypersensitivity reaction \(&lt;2%\)Infection: Infection \(1% to 6%\)Local: Burning sensation at injection site \(?4%\), itching at injection site \(?4%\)Neuromuscular & skeletal: Asthenia \(1% to 4%\), myalgia \(2%\), increased creatine phosphokinase in blood specimen \(&lt;2%\), muscle cramps \(&lt;2%\), neck stiffness \(&lt;2%\), osteoarthritis \(&lt;2%\), tremor \(&lt;2%\)Ophthalmic: Conjunctivitis \(2%\), amblyopia \(&lt;2%\), eye irritation \(&lt;2%\)Otic: Tinnitus \(&lt;2%\)Renal: Polyuria \(&lt;2%\)Respiratory: Pharyngitis \(6%\), dyspnea \(1% to 6%\), bronchitis \(1% to 4%\), flu-like symptoms \(2%\), cough \(1% to 2%\), paranasal sinus congestion \(1% to 2%\), epistaxis \(&lt;2%\), rhinitis \(&lt;2%\)&lt;1%: Atrial flutter, chest pain, sinus node dysfunction, urticaria, ventricular fibrillation, ventricular tachycardiaFrequency not defined: Hepatic: Hepatic injury, increased serum bilirubinPostmarketing: Acute generalized exanthematous pustulosis, alopecia, angioedema, asystole, cutaneous lupus erythematosus \(Crowson 1995; Srivastava 2003\), erythema multiforme, exfoliative dermatitis, extrapyramidal reaction, gingival hyperplasia, hemolytic anemia, hypersensitivity angiitis, leukopenia, myopathy, prolonged bleeding time, purpuric disease, retinopathy, Stevens-Johnson syndrome, thrombocytopenia, toxic epidermal necrolysis |
| 禁忌 | Pregnancy,  Hypersensitivity to diltiazem or any component of the formulation; sick sinus syndrome \(except in patients with a functioning artificial pacemaker\); second- or third-degree AV block \(except in patients with a functioning artificial pacemaker\); hypotension \(systolic &lt;90 mm Hg\); acute MI and pulmonary congestion |
| 藥物保存方式 | 25度C以下避光儲存 |
| 用法用量 | Intial: 90-120mg once daily. MAX: 360 mg/day. |
| 肝功能異常 | 無需調整劑量 |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | Human data suggest low risk |
| 附帶說明 | \[仿單\] 禁忌:孕婦及可能懷孕之婦女 警語:經動物試驗顯示高劑量下對於生殖器官的發育產生不良反應, 建議懷孕及哺乳期婦女僅在絕對必要的情況下才使用 |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | \[仿單\] 警語:經動物試驗顯示高劑量下對於生殖器官的發育產生不良反應, 建議懷孕及哺乳期婦女僅在絕對必要的情況下才使用 |
| 注射劑給藥建議途徑 | AC, AC15, PC, PO, WM |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

## Herbesser 30mg

| 藥物代碼 | OHER |
| :--- | :--- |
| 適應症 | Angina pectoris, mild to moderate essential hypertension. |
| 副作用 | Dizziness, bradycardia, facial flushing, AV block. Fatigue, headache, lightheadedness. Skin rash; GI disturbances, constipation, abdominal pain, heartburn, dyspepsia.Cardiovascular: Bradyarrhythmia \(1.7% to 3.6% \), Peripheral edema \(4.6% to 8% \)Neurologic: Dizziness \(3.5% to 6.4% \), Headache \(4.6% \)Respiratory: Cough \(2% \)Other: Fatigue \(4.8% \) |
| 禁忌 | Sick-sinus syndrome; 2nd or 3rd AV block; porphyria. Severe congestive cardiac failure; marked bradycardia. Pregnancy & lactation.SeriousCardiovascular: Congestive heart failure \(less than 2% \), Heart block, Myocardial infarctionHepatic: Hepatotoxicity |
| 藥物保存方式 | 室溫 |
| 用法用量 | Adult Angina 30 mg tid. May be increased to 60 mg tid. Mild to moderate essential hypertension 30-60 mg tid. |
| 肝功能異常 | 無需調整劑量 |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | Human data suggest low risk |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | N/A |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

